Tag: NASH

All Podcast Categories
S2-E49.3 - Clinical Care Pathway: What Can Be Done Today?

S2-E49.3 – Clinical Care Pathway: What Can Be Done Today?

Last author and leading endocrinology Fatty Liver Opinion Leader Ken Cusi joins co-author Stephen Harrison, Louise Campbell and Roger Green to discuss the recent Clinical Care Pathway published in Gastroenterology. This conversation answers the question “What Can Be Done Today?” in terms of screening and patient management without approved drugs.

S2-E49.2 - Clinical Care Pathway: Behavior Change and Prevalence Data

S2-E49.2 – Clinical Care Pathway: Behavior Change and Prevalence Data

Last author and leading endocrinology Fatty Liver Opinion Leader Ken Cusi joins co-author Stephen Harrison, Louise Campbell and Roger Green to discuss the recent Clinical Care Pathway published in Gastroenterology. This conversation centers on two issues: driving behavior change and recognizing the scope of the need.

S2-E49.1 - Clinical Care Pathway - How It Came To Be

S2-E49.1 – Clinical Care Pathway: How It Came To Be

Last author and leading endocrinology Fatty Liver Opinion Leader Ken Cusi joins co-author Stephen Harrison, Louise Campbell and Roger Green to discuss the recent Clinical Care Pathway published in Gastroenterology. This conversation centers on how the working group came to be and how they developed this pivotal paper.

S2-E48.4 - Closing Thoughts On Summer: What Mattered Most?

S2-E48.4 – Closing Thoughts On Summer: What Mattered Most?

Mazen Noureddin joins Stephen Harrison, Louise Campbell and Roger Green to close our series of “Biggest Stories of NASH Summer.” In this conversation, Roger uses a classical Marketing Research question to help the group sort out the relative impact potential of the ideas they have been discussing.

Looking From a Patient-Based Perspective

S2-E48.3 – Looking From a Patient-Based Perspective

Mazen Noureddin joins Stephen Harrison, Louise Campbell and Roger Green to close our series of “Biggest Stories of NASH Summer.” In this conversation, Louise Campbell raises two very different points about the earlier conversation.

S2-E48.2 – More on FGF-21s and A Topical “Hijacking”

Mazen Noureddin joins Stephen Harrison, Louise Campbell and Roger Green to close our series of “Biggest Stories of NASH Summer.” In this conversation, Stephen Harrison starts by discussing some issues and insights around the use of FGF-21s and then “hijacks” the conversation to explore a standard practice in histopathology that he would like to change.

Join The Discussion…

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"